hepatitis oor Maltees
hepatitis
en
inflammation of the liver, sometimes caused by a viral infection
Vertalings in die woordeboek Engels - Maltees
epatite
In one case, this resulted in subclinical hepatitis which resolved after a dose interruption
F’ każ wieħed dan wassal għal epatite sottoklinika li għaddiet wara li twaqqfet id-doża
Geskatte vertalings
Vertoon algoritmies gegenereerde vertalings
voorbeelde
Advanced filtering
Voorbeelde moet herlaai word.
If you have a chronic hepatitis B infection, you should not stop your treatment with Epivir without instructions from your doctor, as you may have a recurrence of your hepatitis
li jkun sarlu eżami kliniku skond il-Kapitolu IV(D) ta’ l-Anness tad-Deċiżjoni #/#/KE b'riżultati negattivi; uEMEA0.3 EMEA0.3
Compared to subjects with normal hepatic function, patients with mild hepatic impairment had a mean increase in Cmax of # % and in AUC of # % of celecoxib
Il-kwantità mkejla tal-fattur # mogħtija hija dik espressa f’ Unitajiet Internazzjonali (IU), li hija relatata ma ’ l-istandard użati mill-WHO għall-prodotti ta ’ fatturEMEA0.3 EMEA0.3
- adopt a Council recommendation on hepatitis C screening, ensuring early diagnosis and wider access to treatment and care;
Biex ma jsirx xogħol doppju u jitnaqqas l-ammont ta’ informazzjoni, għandha tiġi sottomessa dokumentazzjoni sommarja biss, fejn tikkonċerna l-elementi li huma konformi mat-TSIs u mal-kundizzjonijiet l-oħra tad-Direttivi #/#/KE u #/#/KEEurLex-2 EurLex-2
Tell your doctor if you have had problems with your liver before, including hepatitis B or C
Protokolli li għandhom jiġu annessi mat-Trattat dwar l-Unjoni Ewropea, mat-Trattat dwar il-funzjonament ta' l-Unjoni Ewropea u, skond il-każ, mat-Trattat li jistabbilixxi l-Komunità Ewropea ta' l-Enerġija AtomikaEMEA0.3 EMEA0.3
Monitoring of liver function in patients with known or suspected hepatic disorder is advised during treatment
bil-għan li tiġi stabbilita regola speċjali li tiddeċiedi l-post tal-provvista tas-servizzi tat-telekomunikazzjoni, dawn is-servizzi jeħtieġ li jiġu definitiEMEA0.3 EMEA0.3
In smoking subjects with mild hepatic dysfunction, mean elimination half-life (# hr) was prolonged and clearance (# l/hr) was reduced analogous to non-smoking healthy subjects (# hr and # l/hr, respectively
Suġġett: Epidemija tal-kolera fiż-ŻimbabweEMEA0.3 EMEA0.3
Printed matter, namely, promotional and informational materials in the nature of brochures, pamphlets, newsletters, and stationery relating to pharmaceutical preparations and the treatment and prevention of hepatitis B virus
Għal ċerti bidliet ta’ l-inventarju li huma mniżżla hawn taħt, il-kodiċi li tikkorrispondi maż-żona ta’ bilanċ materjali għandu jiġi rapportattmClass tmClass
Regrets that, despite Parliament's repeated and specific requests, the Commission has yet to propose amending Directive 2000/54/EC with a view to addressing the serious risks to health care workers arising from working with needles and medical sharps; calls on the Commission to expedite the completion of the impact assessment via the Tender (2007/S 139-171103) and calls for an appropriate amendment to be adopted well before the end of the legislature in mid-2009 in line with its abovementioned resolution on protecting European healthcare workers from blood-borne infections due to needlestick injuries; calls on to the Commission to implement appropriate prevention and screening measures to reduce the risk of contracting blood-borne diseases such as hepatitis C;
Il-governanza effikaċi hija kundizzjoni neċessarja biex il-politika ta’ rimunerazzjoni tkun waħda għaqlijanot-set not-set
Induction of hepatic metabolism has not been observed in clinical studies
Il-partijiet li aġixxew b’konformità mas-sentenza preċedenti jistgħu jitolbu seduta ta' smigħ filwaqt li jistipulaw ir-raġunijiet partikolari għaliex għandhom jinstemgħu fil-limitu ta’ żmien stipulat fil-punt #(a)(iiiEMEA0.3 EMEA0.3
Hepatitis A virus specific antibody response
Rapport dwar strateġija koordinata bil-għan li titjieb il-ġlieda kontra l-frodi fiskali [#/#(INI)]- Kumitat għall-Affarijiet Ekonomiċi u MonetarjiEurlex2018q4 Eurlex2018q4
No dose adjustments are needed for renal transplant patients with severe hepatic parenchymal disease
Mingħajr preġudizzju għall-Artikolu #,ir-reġistri taEMEA0.3 EMEA0.3
Infants born of HBsAg-positive mothers should receive Hepatitis B Immune Globulin and Hepatitis B Vaccine (Recombinant) at birth and should complete the hepatitis B vaccination series
Qligħ u telf mhux realizzat fuq il-fondi ta’ kapital tar-riskju u l-investimenti azzjonarji diretti jiġu rrappurtati fir-riżorsi tal-kontributuri sakemm dawn l-investimenti jinbiegħu, jinġabru jew wieħed jiddisponi minnhom, jew sakemm jiġi ddeterminat li dawn l-investimenti huma indebolitiEMEA0.3 EMEA0.3
Insulin and its analogues lower blood glucose levels by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production
Rifużjoni għandha titħallas minn... (b’indikazzjoni tal-Istat Membru u l-isem u l-indirizz sħaħ tal-awtorità kompetenti għall-ħlas tar-rifużjoniEMEA0.3 EMEA0.3
However, the maximum daily dose of # mg should be used with caution in patients with severe hepatic impairment (see section
B’ mod globali, fiż-żewġ studji, il-pazjenti li rċievew IntronA flimkien ma ’ ribavirin, kellhom anqas ċans li jkollhom rispons minn pazjenti li rċievew interferon alfa-#b pegilat flimkien ma ’ ribavirinEMEA0.3 EMEA0.3
Patients with signs or symptoms compatible with autoimmune disorders should be evaluated carefully, and the benefit-risk of continued interferon therapy should be reassessed (see also section # Chronic hepatitis C, Monotherapy (thyroid abnormalities) and section
Attwalment qed issir reviżjoni sħiħa tas-sistema ta' standardizzazzjoniEMEA0.3 EMEA0.3
Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders
Regolament tal-Kummissjoni (KE) Nru #/# tal-# ta' Lulju # li jistabbilixxi projbizzjoni tas-sajd għall-kavalli f' VIIIc, # u X; u fl-ilmijiet tal-KE tas-CECAF #.#.# min-naħa ta' bastimenti li jtajru l-bandiera ta' SpanjaEMEA0.3 EMEA0.3
Patients with hepatic impairment: no dosage adjustment is required for patients with mild to moderate hepatic impairment
It-# ta' Frar #, jew wara li l-Kummissjoni tkun adottat il-pożizzjoni tagħhaEMEA0.3 EMEA0.3
By the 1970’s, the U.S. Centers for Disease Control estimated the number of deaths from transfusion-related hepatitis at 3,500 a year.
fejn A = is-somma pendenti li baqgħet dovuta skond l-Artikolu # fid-data tajw2019 jw2019
In some patients with advanced liver disease or cirrhosis, stopping treatment is not recommended as this may lead to worsening of your hepatitis, which may be life-threatening
preparazzjonijiet ta’ laħam u prodotti tal-laħam kif definiti fil-punti #.# u #.# fl-Anness I tar-Regolament (KE) Nru #/# tal-Parlament Ewropew u tal-Kunsill, u li huma magħmula minn, jew li fihom laħam imsemmi fil-punt (bEMEA0.3 EMEA0.3
Also see ribavirin SPC if Viraferon is to be administered in combination with ribavirin in patients with chronic hepatitis C. lp
it-tkabbir tal-koerenza tal-miżuri politiċi għall-iżviluppEMEA0.3 EMEA0.3
The decision to treat should be made on a case by case basis, taking into account any evidence of disease progression such as hepatic inflammation and fibrosis, as well as prognostic factors for response, HCV genotype and viral load
Raġuni tad-dispaċċ mill-ġdidEMEA0.3 EMEA0.3
No data are available for cardiac or hepatic transplant patients with severe chronic renal impairment
Fi swieq oligopolistiċi l-iskambji ta' informazzjoni sensittiva bħall-prezzijiet u data tal-produzzjoni jistgħu jiffaċilitaw il-kollużjoniEMEA0.3 EMEA0.3
Monitoring of hepatic function
Il-Kummissjoni tixtieq tinnota illi fl-Unjoni Ewropea hemm kompetenzi magħrufa fEMEA0.3 EMEA0.3
In a single dose study, after intravenous administration, the pharmacokinetics of methoxy polyethylene glycol-epoetin beta are similar in patients with severe hepatic impairment as compared to healthy subjects (see section
Ir-riżultati tal-votazzjoni (emendi, votazzjonijiet separati u maqsumin, eċċ) jidhru fl-Anness Riżultati tal-Votazzjonijiet tal-MinutiEMEA0.3 EMEA0.3
Caution should be used, and close monitoring considered when administering interferon beta-#a to patients with severe renal and hepatic failure and to patients with severe myelosuppression
Għall-għanijiet taEMEA0.3 EMEA0.3
202 sinne gevind in 6 ms. Hulle kom uit baie bronne en word nie nagegaan nie.